Hepa Pharma Private Limited, a active private limited company, was established on 10 August 2020 in Tirumalagiri, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24100TG2020PTC142664. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Venkateswara Rao Yarrabathina (Additional Director), Sudheer Kumar Darapureddi (Additional Director). Past directors included Chandana Venkateswara Rao, Dharma Rao Bandi, Jyothi Vantikommu. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 1008, 10Th Floor, Manjeera Trinity Corporate, Jntu-Hitech City Road, Tirumalagiri, Telangana, 500072.
U24100TG2020PTC142664
142664
10 August 2020
₹1.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Hepa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkateswara Rao Yarrabathina | Additional Director | 04 Sep 2021 | Current |
| Sudheer Kumar Darapureddi | Additional Director | 09 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 09 Aug 2024 | Past |
| Pramod Abcsdd | Director | 12 Aug 2021 | Past |
| Pramod Abcsdd | Director | 04 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hepa Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Hepa Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Hepa Pharma has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hepa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hepa Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Hepa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Sudheer Kumar Darapureddi was appointed as a Additional Director was appointed as a Additional Director on 09 Aug 2024 & has been associated with this company since 1 year 5 months . was completed.
Progress on Hepa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity Venkateswara Rao Yarrabathina was appointed as a Additional Director was appointed as a Additional Director on 04 Sep 2021 & has been associated with this company since 4 years 4 months . was completed.
Hepa Pharma Private Limited was registered on 10 Aug 2020 with Roc Hyderabad & aged 5 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Hepa Pharma Private Limited is U24100TG2020PTC142664.
Hepa Pharma Private Limited is headquartered at No. 1008, 10Th Floor, Manjeera Trinity Corporate, Jntu-Hitech City Road, Tirumalagiri, Telangana, 500072.
Hepa Pharma Private Limited was incorporated on 10 August 2020.
The current directors of Hepa Pharma Private Limited are
The primary industry of Hepa Pharma Private Limited is Pharma.
Hepa Pharma Private Limited is unlisted.
The authorized capital of Hepa Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX